Dear Researchers,

Lung cancer imaging is an important aspect of diagnosing and managing lung cancer. There are several imaging modalities that are used to detect and evaluate lung cancer, including chest X-ray, computed tomography (CT) scan, magnetic resonance imaging (MRI), and positron emission tomography (PET) scan.

Chest X-ray is often the first imaging test that is performed to detect lung cancer. It can reveal abnormalities in the lungs, such as nodules or masses, and can also detect other lung conditions such as pneumonia or chronic obstructive pulmonary disease (COPD).

CT scan is a more sensitive imaging test than chest X-ray and can provide a detailed picture of the lungs. CT scans can detect small nodules or masses that may not be visible on a chest X-ray. CT scans can also be used to evaluate the extent of the cancer and whether it has spread to other parts of the body.

MRI is not routinely used for lung cancer imaging but may be useful in certain situations. For example, it may be used to evaluate the extent of the cancer in the chest wall or to detect metastases in the brain or spinal cord.

PET scan is a nuclear imaging test that uses a radioactive tracer to detect cancer cells. It can be used in combination with CT or MRI to provide more detailed information about the location and extent of the cancer.

Overall, the choice of imaging modality depends on the specific situation and the individual patient. So, research articles, reviews and studies in this area of study are welcome. We look forward to receiving your contributions.

Dr. Ashwani Kumar Aggarwal

Section editor